Back to HomeBeta

ICD-10 Coding for Essential Thrombocytosis(D47.3, D75.838)

Complete ICD-10-CM coding and documentation guide for Essential Thrombocytosis. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Essential ThrombocythemiaPrimary ThrombocythemiaIdiopathic Thrombocythemia

Related ICD-10 Code Ranges

Complete code families applicable to Essential Thrombocytosis

D47.3Primary Range

Neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue

This range includes essential thrombocythemia, a primary condition characterized by elevated platelet counts due to clonal proliferation.

Other specified diseases of blood and blood-forming organs

This range includes secondary or reactive thrombocytosis, which is not a primary clonal disorder.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
D47.3Essential (hemorrhagic) thrombocythemiaUse when documentation specifies essential or primary thrombocythemia with supporting lab results.
  • Platelet count ≥450 x10³/µL
  • Presence of JAK2, CALR, or MPL mutations
  • Exclusion of reactive causes
D75.838Other specified thrombocytosisUse when thrombocytosis is secondary to another condition, such as infection or inflammation.
  • Documentation of underlying cause
  • Transient platelet elevation

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for essential thrombocytosis

Essential facts and insights about Essential Thrombocytosis

The ICD-10 code for essential thrombocytosis is D47.3, used when confirmed by genetic testing.

Primary ICD-10-CM Codes for essential thrombocytosis

Essential (hemorrhagic) thrombocythemia
Billable Code

Decision Criteria

clinical Criteria

  • Presence of JAK2, CALR, or MPL mutations

documentation Criteria

  • Explicit mention of 'essential' or 'primary' thrombocythemia

Applicable To

  • Primary thrombocythemia
  • Idiopathic thrombocythemia

Excludes

Clinical Validation Requirements

  • Platelet count ≥450 x10³/µL
  • Presence of JAK2, CALR, or MPL mutations
  • Exclusion of reactive causes

Code-Specific Risks

  • Misclassification if genetic testing is not documented
  • Incorrect use if reactive causes are not excluded

Coding Notes

  • Ensure documentation specifies 'essential' or 'primary' to use D47.3.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Personal history of leukemia

Z85.6
Use if there is a history of leukemia progression from essential thrombocythemia.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Other specified thrombocytosis

D75.838
Reactive thrombocytosis is secondary to another condition, such as infection or inflammation.

Essential (hemorrhagic) thrombocythemia

D47.3
Essential thrombocythemia is a primary clonal disorder with specific genetic markers.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Essential Thrombocytosis to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code D47.3.

Impact

Clinical: Potential misdiagnosis and inappropriate treatment., Regulatory: Non-compliance with documentation standards., Financial: Claim denials due to insufficient documentation.

Mitigation Strategy

Educate providers on documentation requirements, Implement checklist for thrombocytosis documentation

Impact

Reimbursement: Potential denial of claims due to lack of supporting documentation., Compliance: Non-compliance with coding guidelines requiring specific documentation., Data Quality: Inaccurate clinical data affecting patient records.

Mitigation Strategy

Ensure documentation includes genetic testing results or query the provider.

Impact

Lack of genetic testing documentation for essential thrombocythemia.

Mitigation Strategy

Ensure all cases of D47.3 have documented genetic test results.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Essential Thrombocytosis, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Essential Thrombocytosis

Use these documentation templates to ensure complete and accurate documentation for Essential Thrombocytosis. These templates include all required elements for proper coding and billing.

Hematology Progress Note for Essential Thrombocythemia

Specialty: Hematology

Required Elements

  • Diagnosis confirmation
  • Genetic testing results
  • Platelet count trends
  • Exclusion of reactive causes
  • Treatment plan

Example Documentation

Diagnosis: Essential thrombocythemia confirmed by JAK2 V617F mutation. Platelets: 780 x10³/µL. Plan: Start hydroxyurea.

Examples: Poor vs. Good Documentation

Poor Documentation Example
High platelets, monitor.
Good Documentation Example
Essential thrombocythemia confirmed by JAK2 V617F mutation. Platelets: 780 x10³/µL. Plan: Start hydroxyurea.
Explanation
The good example specifies the diagnosis, genetic confirmation, and treatment plan.

Need help with ICD-10 coding for Essential Thrombocytosis? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more